Tubulis Technologies announced that it has received oversubscribed ?128 Million in round of funding co-led by new investors EQT Life Sciences and Nextech Invest Ltd. on March 14, 2024. The transaction included the participation from new investors Frazier Life Sciences Management, LP and Deep Track Capital, LP, returning investors Andera Partners, BioMedPartners AG, Fund+ NV, Bayern Kapital GmbH, Evotec SE, Coparion GmbH & Co. KG, Seventure Partners, Occident Group AG and High-Tech Gründerfonds Management GmbH.

Christoph Broja for EQT Life Sciences and Kanishka Pothula for Nextech Invest Ltd. will join the company's board of directors.